Back to Search
Start Over
68 Gallium–Prostate-Specific Membrane Antigen PET/Computed Tomography for Primary and Secondary Staging in Prostate Cancer
- Source :
- Urologic Clinics of North America. 44:557-563
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
-
Abstract
- Prostate-specific membrane antigen (PSMA) PET has been recently introduced for the diagnosis of patients with metastatic prostate cancer (PCa). Until today, staging of patients with PCa relied mostly on morphologic features, such as size or shape, resulting in low detection rates in disease recurrence. PSMA PET imaging provides molecular information and, in combination with conventional imaging, offers improved sensitivity and specificity. This review discusses the benefits and limitations of PSMA imaging in the setting of primary staging and detection of recurrent disease in comparison with standard-of-care imaging techniques.
- Subjects :
- Biochemical recurrence
Oncology
medicine.medical_specialty
PET-CT
medicine.diagnostic_test
business.industry
Urology
Computed tomography
urologic and male genital diseases
medicine.disease
030218 nuclear medicine & medical imaging
03 medical and health sciences
Prostate cancer
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Psma pet
medicine
Glutamate carboxypeptidase II
Recurrent disease
Radiology
Prostate cancer staging
business
Subjects
Details
- ISSN :
- 00940143
- Volume :
- 44
- Database :
- OpenAIRE
- Journal :
- Urologic Clinics of North America
- Accession number :
- edsair.doi...........0b50e67aac8c2d8573f0fc573d7c2e5d